Allovir Inc., of Cambridge, Mass., appointed Ugo Capolino Perlingieri general manager of Europe and Middle East operations.
Apellis Pharmaceuticals Inc., of Waltham, Mass., appointed Paul Fonteyne to its board.
Constellation Pharmaceuticals Inc., of Cambridge, Mass., appointed Richard Levy to its board.
Egenesis Inc., of Cambridge, Mass., appointed David A. Carmel senior vice president, public affairs and communications.
Emergent Biosolutions Inc., of Gaithersburg, Md., appointed Nina DeLorenzo senior vice president for global public affairs.
Gritstone Oncology Inc., of Emeryville, Calif., appointed Rahsaan W. Thompson executive vice president and general counsel.
Immunomedics Inc., of Morris Plains, N.J., appointed Harout Semerjian president and CEO and to its board, effective April 16, 2020.
Obseva SA, of Geneva, appointed Fabien de Ladonchamps interim chief financial officer and member of the executive committee, effective April 10, 2020.
Polarityte Inc., of Salt Lake City, appointed Chris Nolet to its board and chair of its audit committee.
Rafarma Pharmaceuticals Inc., of Ljubljana, Slovenia, appointed Vladislav N. Laskavy to its board.
Seres Therapeutics Inc., of Cambridge, Mass., appointed Lisa von Moltke executive vice president and chief medical officer.